ArticleFrontiers in immunology2025

NOS2/ARG1 axis and immune cell ratios as promising prognostic and predictive biomarkers for Cetuximab combined with chemotherapy in wt-KRAS human colorectal cancer.

Djehane Houria Mataam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.